Genetic study of idiopathic epilepsy clinical cases in dogs
Purpose
To obtain a DNA sample from dogs that have been diagnosed and are currently being treating, or newly diagnosed pets, for idiopathic epilepsy. These pets do not have to be on any specific diet, can be at any stage of seizure management, and can be either sensitive or resistant to anti-epileptic drug (AED) therapy.
Process
Simply a 30 second swab inside the cheek to obtain an adequate saliva sample.
Benefits
No direct incentive to the client but with the information obtained we hope to be able to have a better understand of the genes associated with idiopathic epilepsy in order to better diagnose, manage, and treat this disease in our canine companions.
Cost
There is no cost associated with this study
condition(s)
eligibility information
- Dogs of all breeds, all size, aged 12 months minimum for small breed dogs and 18 months for large breed
dogs, male or female, neutered/spayed or entire with no age maximum. - Dogs of any weightSuffering from an idiopathic epilepsy with clear clinical signs (ideally with
- unremarkable former MRI
scan) - Dogs with AED sensitive IE
- For dogs with AED resistant IE
- For which the owners have signed an agreement form
Enrollment Deadline
Enrollment ends December 31, 2020
contact information
If you’re interested in enrolling your dog in this study please contact csuneurotrials@colostate.edu to set up a time for us to get a saliva swab from your dog.
